Layoffs By PowerPoint?

Merck announced last week that it will cut 1,200 sales jobs in the U.S. by the end of July. The company also confirmed a plan to eliminate a small natural products group in Spain and Rahway, NJ. Whereas the salespeople who lost their jobs were given notice by the company, the natural products researchers in Spain (and Rahway) learned of their imminent demise via a power point presentation given by a Merck executive (whose name has not been disclosed).

According to reports, the Merck executive inadvertently included a slide in his presentation that outlined the plan for the layoffs to an audience that included Merck employees. Oops… The decision to close down in-house natural products research will impact approximately 50 researchers in Spain and "a significantly smaller number" in Rahway, N.J., according to Merck spokesman.

Merck eliminated most of its natural products discovery programs about 10 years ago but apparently maintained a small group hoping for a natural products discovery comeback. I, along with others, think that the blockbuster drugs of the future will come from natural product discovery. For those doubters out there, would somebody care to tell me the names of any blockbuster drugs that were discovered by combinatorial and computational chemistry?

I rest my case! 

Thanks to Ed over at Pharmalot for the heads up on this story!!!!!

Until next time…

Good Luck and Good Job Hunting!!!!!!!!!!!!

Teva to Add 165 New Jobs to Irish Manufacturing Plant

Teva Pharmaceuticals announced  yesterday that it will invest €65 million in its facility in Waterford, Ireland, and that it is creating an additional 165 new jobs over five years. Teva has three pharmaceutical plants and a research and development facility on its Waterford campus which was previously owned by IVAX Corporation. The expansion has been helped by grants from Ireland’s inward investment promotion agency, IDA Ireland. 

The existing facility supplies Teva's European respiratory products and also makes a range of treatments for the US market. The site is also Teva’s main research centre for respiratory products. The investment is expected to double the production capacity of both its inhaler and tablet manufacturing capacity. Pharmaceutical Industries Ltd. acquired the respiratory products business as part of its acquisition of the IVAX Corporation in January 2006. 

This is good news for the Irish pharmaceutical manufacturing industry which has been experiencing something of a slow down over the past year or so.

Until next time….

Good Luck and Good Job Hunting!!!!!!